Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of crystallization method for preparing high-purity and monodisperse I crystal form atorvastatin calcium in two kettles

A monodisperse technology of atorvastatin calcium, applied in organic chemistry methods, organic chemistry, etc., can solve the problems of easy aggregation of particles and difficult purification

Active Publication Date: 2022-04-05
BEIJING JIALIN PHARM INC +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0054] The present invention aims at the problems of difficulty in purification during the crystallization and refining process of preparation of I crystal form atorvastatin calcium bulk drug, and easy aggregation of particles. The present invention provides a new method for crystallization of I crystal form atorvastatin calcium. Nucleation process control and suspension crystallization in flow elution crystallization process to obtain high purity and monodisperse crystalline form I atorvastatin calcium powder

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of crystallization method for preparing high-purity and monodisperse I crystal form atorvastatin calcium in two kettles
  • A kind of crystallization method for preparing high-purity and monodisperse I crystal form atorvastatin calcium in two kettles
  • A kind of crystallization method for preparing high-purity and monodisperse I crystal form atorvastatin calcium in two kettles

Examples

Experimental program
Comparison scheme
Effect test

Embodiment example 1

[0104] Dissolving 7 g of atorvastatin calcium raw material in 40 g of anhydrous methanol at a temperature of 20 to 25° C., and the methanol solution obtained after pressure filtration is used as a feed solution for co-current elution and crystallization.

[0105] In crystallizer, adding methanol content is the methanol-water solution of 65wt% as the solution of elution crystallization, and solution gross mass is 40g, is warming up to 65 ℃, drops into 0.6g I crystal form atorvastatin calcium crystallization powder wherein, makes solution When saturation is reached, 0.2 g of I crystal form atorvastatin calcium is added thereto, suspended and transformed for 1 hour as a seed crystal.

[0106] Using the co-current elution method, the material liquid and the anti-solvent pure water are added to the crystallizer at the same time. Each material is divided into two streams and added. The process time is 8 hours. The methanol content of the solvent in the solution is kept constant durin...

Embodiment example 2

[0114] Dissolve 7 g of atorvastatin calcium raw material in 40 g of anhydrous methanol at a temperature of 20-25° C., and press-filter the resulting methanol solution as a feed solution for co-current elution and crystallization.

[0115] In crystallizer, adding methanol content is the methanol-water solution of 50wt% as the solution of elution crystallization, and solution gross mass is 40g, is warming up to 65 ℃, drops into 0.489g I crystal form atorvastatin calcium crystallization powder wherein, makes solution When saturation is reached, 0.2 g of I crystal form atorvastatin calcium is added thereto, suspended and transformed for 1 hour as a seed crystal.

[0116] The methanol feed liquid and the anti-solvent pure water were added to the crystallizer at the same time, and each material was divided into two feeds. The process time was 8 hours, and the methanol content of the solvent in the solution was kept constant during the entire dissolution process.

[0117] The tempera...

Embodiment example 3

[0124] Dissolve 7 g of atorvastatin calcium raw material in 40 g of anhydrous methanol at a temperature of 20-25° C., and press-filter the resulting methanol solution as a feed solution for co-current elution and crystallization.

[0125] In crystallizer, add methanol content and be the methanol-water solution of 40wt% as the solution of elution crystallization, solution gross mass is 40g, be warming up to 65 ℃, drop into 0.3g I crystal form atorvastatin calcium crystallization powder wherein, make solution When saturation is reached, 0.2 g of I crystal form atorvastatin calcium is added thereto, suspended and transformed for 1 hour as a seed crystal.

[0126] Add the methanol feed liquid and pure water to the crystallizer at the same time, each material is divided into two feeds, the process time is 8h, and the methanol content of the solvent in the solution is kept constant during the whole dissolution process.

[0127] Lower the temperature of the solution to normal tempera...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to a crystallization method for preparing high-purity and monodisperse crystal form I atorvastatin calcium in a double kettle. The method comprises the following steps: in the first step, adding and dissolving atorvastatin calcium into a crystallizer at a certain temperature To reach a saturated solution, add atorvastatin calcium powder to suspend as a seed crystal, then add the anti-solvent and the good solvent for dissolving atorvastatin calcium into the solution at the same time according to the proportion of the solvent in the solution to complete the dissolution and crystallization process, and finally cool down Centrifuge and wash at 20°C to obtain the crystal form of atorvastatin calcium in a mixed solvent; in the second step, disperse the filter cake obtained in the first step in the pure water of the stirred tank crystallizer or with a higher water content Suspended and transformed crystals in a mixed solvent at a certain temperature, then cooled to 20°C, filtered, washed with pure water and dried to obtain atorvastatin calcium in I crystal form.

Description

technical field [0001] The present application relates to a crystallization method of an atorvastatin calcium bulk drug, in particular to the purification of the bulk drug, the preparation of I crystal form and the particle size control method of the crystal. [0002] technical background [0003] Atorvastatin calcium, the full chemical name is [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- Calcium 3-phenyl-4-[(anilino)carbonyl]-1H-pyrrole-1-heptanoate. Molecular formula is C 66 h 68 o 10 N 4 f 2 Ca, molecular weight 1155.42, structural formula as follows [0004] [0005] Atorvastatin Calcium is a white or off-white crystalline powder, odorless and bitter in taste. It is a blood lipid-lowering drug that can effectively regulate the blood lipid content in the blood. The substance is easily soluble in methanol, slightly soluble in ethanol or acetone, very slightly soluble in water, almost insoluble or insoluble in chloroform and ether. [0006] Comm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D207/34
CPCC07D207/34C07B2200/13
Inventor 龚俊波秦春雷侯晓清
Owner BEIJING JIALIN PHARM INC